Aprea Therapeutics, Inc.
APRE
$1.59
-$0.0324-2.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 15.93% | -18.08% | -6.47% | 35.84% | -41.00% |
| Total Depreciation and Amortization | 8.00% | 285.71% | 2,550.00% | 1,450.00% | 308.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.25% | 133.97% | -37.09% | -1.00% | 77.47% |
| Change in Net Operating Assets | -53.04% | 27.58% | -81.81% | -184.76% | 72.23% |
| Cash from Operations | 6.12% | -10.09% | -13.20% | -32.12% | 6.98% |
| Capital Expenditure | 100.00% | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 176.38% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -98.78% | -- |
| Cash from Financing | -- | -- | -- | 186.18% | -100.00% |
| Foreign Exchange rate Adjustments | -6,250.00% | 826.47% | 91.03% | -104.98% | 100.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.22% | -4.87% | -12.37% | 387.23% | 13.40% |